NCT00864279View on ClinicalTrials.gov

A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

Cetirizine Hydrochloride 10 mg tablets, single dose

A: Experimental Subjects received Shasun Chemicals and Drugs Ltd. formulated products under fast conditions

DRUG

Zyrtec® 10 mg tablets, single dose

B: Active comparator Subjects received Pfizer Inc. formulated products under fast conditions

Trial Locations (1)

27560

AAIPharma Inc.- AAI Clinic, Morrisville

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00864279 - A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter